-

Rambam Study Shows Cancer Patients with Solid Tumors Respond to COVID Vaccinations Like the General Population
October 5, 2021 – Studies conducted in Rambam’s Joseph Fishman Oncology Center are proving the efficacy and safety of COVID-19 vaccinations for cancer patients with solid tumors, and vaccinations—indicating a favorable profile. Following a study conducted last year in Joseph Fishman Oncology Center at Rambam Health Care Campus regarding the outcomes of COVID-19 in cancer patients, a team of researchers in the facility, led by Professor Irit Ben-Aharon, Director of the Division of Oncology, followed the vaccine outcomes…
-

Rambam Expert Raises Epilepsy Awareness via Training Sessions for Educators
September 30, 2021 – Several training sessions were designed for the Israeli educational system to reduce the stigmas associated with epilepsy. The sessions provided tools for educators to use when assisting students suffering from the disorder. Educational staff have dedicated countless hours preparing for the school year, which began in early September. This year, the second to begin against the backdrop of the COVID-19 pandemic, the educational teams prepared by utilizing a hybrid approach that…
-

Rambam Physician Heads International Hematology Conference
September 26, 2021 – For the first time ever, an international conference dealing with immune system and blood clotting issues was hosted by Israel. The conference was organized and led by Dr. Lilach Bonstein, Director of the Blood Bank Laboratory at Rambam Health Care Campus. Dr. Lilach Bonstein, Director of the Blood Bank Laboratory at Rambam Health Care Campus who also serves as Director of the Platelet and Neutrophil Immunology Laboratory, is the first Israeli…
-

The Word “Lockdown” Needs to Disappear from Our Lexicon
September 12, 2021 – Professor Rafi Beyar, the former General Director of Rambam Health Care Campus, remains deeply committed to quality healthcare. Drawing from his own experience and expertise over the years, he has written an informative and thought-provoking editorial for the daily Israeli business news website “Globes”. A new virus has entered our world and become a reality in our lives. At first, we were afraid—we did not know the enemy—and we were all…
-

The Battle against the Coronavirus is a War in Every Sense – We Need to Focus on Both the Frontlines and the Home Front
September 12, 2021 – Dr. Michael Halberthal, Director General of Rambam Health Care Campus, has been tirelessly leading the hospital through the daily challenges of the coronavirus. Below is an editorial he wrote for the Israeli daily newspaper and news website, “Israel Today”. At the beginning of March 2020, the first patient to be diagnosed with COVID-19 entered the gates of our hospital. Today, more than a year-and-a-half later, we are far from the end…
-

Human Interest Story: Rambam Radiographer Saves Life of Drowning Man
August 29, 2021 – A radiographer employed at Rambam Health Care Campus helped perform CPR on a man who suffered a seizure and almost drowned, saving his life. Walaa Sabbagh, a radiographer at Rambam Health Care Campus for the past four years, was spending the day with her family at Gan HaShlosha (Sahne) National Park, when she suddenly heard screams coming from several meters away. Without thinking, Sabbagh jumped up and ran towards the screaming.…
-

Preparations for the New School Year at Ruth Rappaport Children’s Hospital
The 2021–2022 school year will open as scheduled for hospitalized children at the Ruth Rappaport Children’s Hospital of Rambam Health Care Campus. The hospital’s school is run by the BRACHA Education Center under the direction of Israel’s Ministry of Education August 26, 2021 – At Rambam, ten classes are held for hospitalized children ages 3 to 21, including those children who will enter first grade while in hospital. The educations staff invest several days of careful organization and preparation in…
-

Possible COVID Breakthrough: Israeli Ministry of Health Approves Extension of Israeli Drug Trial at Rambam Medical Center to Other Israel Hospitals
August 11, 2021 – The Israeli Ministry of Health confirmed that hospitals will begin treating critically ill COVID-19 patients with a new Israeli drug called “MesenCure“ manufactured by Bonus BioGroup. The decision was made after recent clinical trials with the experimental drug at Rambam, with good results: 14 out of 16 seriously ill COVID-19 patients treated with the drug were discharged from the hospital. Click the link below to learn more- https://www.jpost.com/health-science/israel-to-expand-use-of-covid-drug-that-gets-88-percent-of-patients-out-of-hospital-676397 Treatment with MesenCure…
-

Global Breakthrough: Rambam Physicians Perform Cryotherapy to Remove Superficial Bladder Cancer
August 8, 2021 – Cryotherapy has been performed for the first time in the world to treat superficial bladder cancer in a 60-year-old patient. The minimally invasive procedure represented a collaboration between Rambam Health Care Campus’s Department of Urology led by Professor Gilad Amiel and Dr. Isaac Hoffman, and representatives of Vessi Medical founded by Mr. Eyal Kochavi. Bladder cancer is the most common type of cancer occurring in men over the age of 55, and…
-

Rambam Participates In Historic Israel-UAE Organ Exchange—First Ever With An Arab State
August 1, 2021 – Rambam Health Care Campus participated in a unique kidney transplant arrangement involving donors and recipients in Israel and the United Arab Emirates. https://www.timesofisrael.com/3-women-receive-kidneys-in-israel-uae-organ-exchange-1st-with-arab-state/ Last Wednesday, at 18:30 it happened – an ambulance arrived with flashing lights from Ben Gurion airport with a kidney for a woman who has been waiting for five years. This was part of a complicated cross-transplant operation of the National Center for Organ transplants. Doctors at Sheba…
-

The 2021 Rambam Summit & Gala: Looking Back & Moving Forward
Highlights from the 2021 Rambam Summit & Gala — looking back on the year and ahead to what’s next for Rambam and its American friends.

